vosoritide 1.2 MG Injection [Voxzogo]
- RxCUI
- 2586377
- RxNorm name
- vosoritide 1.2 MG Injection [Voxzogo]
- Display name
- vosoritide 1.2 MG Injection [Voxzogo]
- Full name
- vosoritide 1.2 MG Injection [Voxzogo]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:50
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VOXZOGO 0.4mg | VOSORITIDE | BioMarin Pharmaceutical Inc. | 228e8560-04a4-4bb1-a81f-29531a9e4d27 | 2025-11-25 | Warnings, Adverse reactions | 2586377 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 228e8560-04a4-4bb1-a81f-29531a9e4d27 | vosoritide 1.2 MG Injection [Voxzogo] | SBD | 16 | These highlights do not include all the information needed to use VOXZOGO safely and effectively. See full prescribing information for VOXZOGO. VOXZOGO (vosoritide) for injection, for subcutaneous use Initial U.S. Approval: 2021 | 20251125 |
| 228e8560-04a4-4bb1-a81f-29531a9e4d27 | Voxzogo 1.2 MG Injection | SY | 16 | These highlights do not include all the information needed to use VOXZOGO safely and effectively. See full prescribing information for VOXZOGO. VOXZOGO (vosoritide) for injection, for subcutaneous use Initial U.S. Approval: 2021 | 20251125 |
| 228e8560-04a4-4bb1-a81f-29531a9e4d27 | VOXZOGO 1.2 MG Injection | PSN | 16 | These highlights do not include all the information needed to use VOXZOGO safely and effectively. See full prescribing information for VOXZOGO. VOXZOGO (vosoritide) for injection, for subcutaneous use Initial U.S. Approval: 2021 | 20251125 |